AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST
The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | XIAO, Yushi YU, Tao MCCORMICK, Kevin D WU, Heping ZHANG, Yonglian KUANG, Rongze LO, Michael Man-Chu LIM, Yeon-Hee XIAO, Dong TING, Pauline C WU, Jie TAGAT, Jayaram R KIM, David Won-Shik ALI, Amjad DEGRADO, Sylvia J ZHU, Xiaohong CAO, Jianhua LEE, Joe F KHAN, Tanweer HENDERSON, Timothy J TUNG, Alexander L KIM, Jae-Hun HONG, Liwu RUIZ, Manuel de Lera BIJU, Purakkattle BERLIN, Michael ZHOU, Gang |
| description | The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3253390B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3253390B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3253390B13</originalsourceid><addsrcrecordid>eNrjZNBx9PX08w8M9fRzjPL38fRzVXD29w3wD_VzCVZwBCIjRwVHvxBHd38_z-AQHgbWtMSc4lReKM3NoODmGuLsoZtakB-fWlyQmJyal1oS7xpgbGRqbGxp4GRoTIQSAGS8JOo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST</title><source>esp@cenet</source><creator>XIAO, Yushi ; YU, Tao ; MCCORMICK, Kevin D ; WU, Heping ; ZHANG, Yonglian ; KUANG, Rongze ; LO, Michael Man-Chu ; LIM, Yeon-Hee ; XIAO, Dong ; TING, Pauline C ; WU, Jie ; TAGAT, Jayaram R ; KIM, David Won-Shik ; ALI, Amjad ; DEGRADO, Sylvia J ; ZHU, Xiaohong ; CAO, Jianhua ; LEE, Joe F ; KHAN, Tanweer ; HENDERSON, Timothy J ; TUNG, Alexander L ; KIM, Jae-Hun ; HONG, Liwu ; RUIZ, Manuel de Lera ; BIJU, Purakkattle ; BERLIN, Michael ; ZHOU, Gang</creator><creatorcontrib>XIAO, Yushi ; YU, Tao ; MCCORMICK, Kevin D ; WU, Heping ; ZHANG, Yonglian ; KUANG, Rongze ; LO, Michael Man-Chu ; LIM, Yeon-Hee ; XIAO, Dong ; TING, Pauline C ; WU, Jie ; TAGAT, Jayaram R ; KIM, David Won-Shik ; ALI, Amjad ; DEGRADO, Sylvia J ; ZHU, Xiaohong ; CAO, Jianhua ; LEE, Joe F ; KHAN, Tanweer ; HENDERSON, Timothy J ; TUNG, Alexander L ; KIM, Jae-Hun ; HONG, Liwu ; RUIZ, Manuel de Lera ; BIJU, Purakkattle ; BERLIN, Michael ; ZHOU, Gang</creatorcontrib><description>The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220413&DB=EPODOC&CC=EP&NR=3253390B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220413&DB=EPODOC&CC=EP&NR=3253390B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XIAO, Yushi</creatorcontrib><creatorcontrib>YU, Tao</creatorcontrib><creatorcontrib>MCCORMICK, Kevin D</creatorcontrib><creatorcontrib>WU, Heping</creatorcontrib><creatorcontrib>ZHANG, Yonglian</creatorcontrib><creatorcontrib>KUANG, Rongze</creatorcontrib><creatorcontrib>LO, Michael Man-Chu</creatorcontrib><creatorcontrib>LIM, Yeon-Hee</creatorcontrib><creatorcontrib>XIAO, Dong</creatorcontrib><creatorcontrib>TING, Pauline C</creatorcontrib><creatorcontrib>WU, Jie</creatorcontrib><creatorcontrib>TAGAT, Jayaram R</creatorcontrib><creatorcontrib>KIM, David Won-Shik</creatorcontrib><creatorcontrib>ALI, Amjad</creatorcontrib><creatorcontrib>DEGRADO, Sylvia J</creatorcontrib><creatorcontrib>ZHU, Xiaohong</creatorcontrib><creatorcontrib>CAO, Jianhua</creatorcontrib><creatorcontrib>LEE, Joe F</creatorcontrib><creatorcontrib>KHAN, Tanweer</creatorcontrib><creatorcontrib>HENDERSON, Timothy J</creatorcontrib><creatorcontrib>TUNG, Alexander L</creatorcontrib><creatorcontrib>KIM, Jae-Hun</creatorcontrib><creatorcontrib>HONG, Liwu</creatorcontrib><creatorcontrib>RUIZ, Manuel de Lera</creatorcontrib><creatorcontrib>BIJU, Purakkattle</creatorcontrib><creatorcontrib>BERLIN, Michael</creatorcontrib><creatorcontrib>ZHOU, Gang</creatorcontrib><title>AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST</title><description>The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBx9PX08w8M9fRzjPL38fRzVXD29w3wD_VzCVZwBCIjRwVHvxBHd38_z-AQHgbWtMSc4lReKM3NoODmGuLsoZtakB-fWlyQmJyal1oS7xpgbGRqbGxp4GRoTIQSAGS8JOo</recordid><startdate>20220413</startdate><enddate>20220413</enddate><creator>XIAO, Yushi</creator><creator>YU, Tao</creator><creator>MCCORMICK, Kevin D</creator><creator>WU, Heping</creator><creator>ZHANG, Yonglian</creator><creator>KUANG, Rongze</creator><creator>LO, Michael Man-Chu</creator><creator>LIM, Yeon-Hee</creator><creator>XIAO, Dong</creator><creator>TING, Pauline C</creator><creator>WU, Jie</creator><creator>TAGAT, Jayaram R</creator><creator>KIM, David Won-Shik</creator><creator>ALI, Amjad</creator><creator>DEGRADO, Sylvia J</creator><creator>ZHU, Xiaohong</creator><creator>CAO, Jianhua</creator><creator>LEE, Joe F</creator><creator>KHAN, Tanweer</creator><creator>HENDERSON, Timothy J</creator><creator>TUNG, Alexander L</creator><creator>KIM, Jae-Hun</creator><creator>HONG, Liwu</creator><creator>RUIZ, Manuel de Lera</creator><creator>BIJU, Purakkattle</creator><creator>BERLIN, Michael</creator><creator>ZHOU, Gang</creator><scope>EVB</scope></search><sort><creationdate>20220413</creationdate><title>AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST</title><author>XIAO, Yushi ; YU, Tao ; MCCORMICK, Kevin D ; WU, Heping ; ZHANG, Yonglian ; KUANG, Rongze ; LO, Michael Man-Chu ; LIM, Yeon-Hee ; XIAO, Dong ; TING, Pauline C ; WU, Jie ; TAGAT, Jayaram R ; KIM, David Won-Shik ; ALI, Amjad ; DEGRADO, Sylvia J ; ZHU, Xiaohong ; CAO, Jianhua ; LEE, Joe F ; KHAN, Tanweer ; HENDERSON, Timothy J ; TUNG, Alexander L ; KIM, Jae-Hun ; HONG, Liwu ; RUIZ, Manuel de Lera ; BIJU, Purakkattle ; BERLIN, Michael ; ZHOU, Gang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3253390B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>XIAO, Yushi</creatorcontrib><creatorcontrib>YU, Tao</creatorcontrib><creatorcontrib>MCCORMICK, Kevin D</creatorcontrib><creatorcontrib>WU, Heping</creatorcontrib><creatorcontrib>ZHANG, Yonglian</creatorcontrib><creatorcontrib>KUANG, Rongze</creatorcontrib><creatorcontrib>LO, Michael Man-Chu</creatorcontrib><creatorcontrib>LIM, Yeon-Hee</creatorcontrib><creatorcontrib>XIAO, Dong</creatorcontrib><creatorcontrib>TING, Pauline C</creatorcontrib><creatorcontrib>WU, Jie</creatorcontrib><creatorcontrib>TAGAT, Jayaram R</creatorcontrib><creatorcontrib>KIM, David Won-Shik</creatorcontrib><creatorcontrib>ALI, Amjad</creatorcontrib><creatorcontrib>DEGRADO, Sylvia J</creatorcontrib><creatorcontrib>ZHU, Xiaohong</creatorcontrib><creatorcontrib>CAO, Jianhua</creatorcontrib><creatorcontrib>LEE, Joe F</creatorcontrib><creatorcontrib>KHAN, Tanweer</creatorcontrib><creatorcontrib>HENDERSON, Timothy J</creatorcontrib><creatorcontrib>TUNG, Alexander L</creatorcontrib><creatorcontrib>KIM, Jae-Hun</creatorcontrib><creatorcontrib>HONG, Liwu</creatorcontrib><creatorcontrib>RUIZ, Manuel de Lera</creatorcontrib><creatorcontrib>BIJU, Purakkattle</creatorcontrib><creatorcontrib>BERLIN, Michael</creatorcontrib><creatorcontrib>ZHOU, Gang</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XIAO, Yushi</au><au>YU, Tao</au><au>MCCORMICK, Kevin D</au><au>WU, Heping</au><au>ZHANG, Yonglian</au><au>KUANG, Rongze</au><au>LO, Michael Man-Chu</au><au>LIM, Yeon-Hee</au><au>XIAO, Dong</au><au>TING, Pauline C</au><au>WU, Jie</au><au>TAGAT, Jayaram R</au><au>KIM, David Won-Shik</au><au>ALI, Amjad</au><au>DEGRADO, Sylvia J</au><au>ZHU, Xiaohong</au><au>CAO, Jianhua</au><au>LEE, Joe F</au><au>KHAN, Tanweer</au><au>HENDERSON, Timothy J</au><au>TUNG, Alexander L</au><au>KIM, Jae-Hun</au><au>HONG, Liwu</au><au>RUIZ, Manuel de Lera</au><au>BIJU, Purakkattle</au><au>BERLIN, Michael</au><au>ZHOU, Gang</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST</title><date>2022-04-13</date><risdate>2022</risdate><abstract>The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3253390B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A24%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XIAO,%20Yushi&rft.date=2022-04-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3253390B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |